Settlement of opioid law suits delayed as state and local governments wrangle
Drugmakers are accused of pushing opioid prescriptions on doctors across the US and downplaying the risks of addiction
Delaware/New York — About $50bn in settlement offers by drugmakers and distributors have sparked a fight between state attorneys general and thousands of local governments over how much the pharmaceutical industry should pay for its role in creating the US opioid epidemic.
Drugmaker Teva said Monday it offered $23bn in treatment medications and $250m towards a settlement of more than 2,700 lawsuits by states and municipalities. That follows a proposal by Johnson & Johnson for $4bn and another for $18bn by opioid distributors McKesson, Cardinal Health and AmerisourceBergen, along with $2.5bn in distribution services...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.